معرفی
Shengxin Liu is a Postdoctoral Researcher at the Karolinska Institutet since 2023, affiliated with the Department of Medical Epidemiology and Biostatistics and Lu Yi's Precision Psychiatry research group. Funded by the Swedish Research Council, their work bridges mental and metabolic health using -omic data, particularly metabolomics, to address heterogeneity in major depressive disorder and comorbidity with diabetes.
- Education: PhD in Medical Epidemiology and Biostatistics (Karolinska Institutet, 2023)
Research focuses on metabolic dysregulation in psychiatric subtyping, integrating epidemiological frameworks with bioinformatics for molecular and population-level insights. Their publications span diabetes, psychiatry, neurodevelopmental disorders, and perinatal immunology, emphasizing real-world healthcare applications.
Key awards include the Swedish Research Council International Postdoc Grant (2023) and a grant for metabolomics research in depression (2024-2027). Supervision includes Nishan Lamichhane and Lian Meijie on psychotropic medication economics. Collaborations involve institutions like the University of Edinburgh and diabetes/endocrinology research networks.
